KEGG pathway analysis further revealed that LOXL2 may activate the FAK/PI3K-Akt signaling axis through ECM-receptor interaction (Figures 4G, H), suggesting its potential role in glioma immune escape. The gene discussed is PTK2; the disease is central nervous system cancer.